Applied Therapeutics Inc Asset Turnover Ratio (APLT), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Applied Therapeutics Inc   (NASDAQ: APLT)
 

Applied Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Applied Therapeutics Inc asset turnover ratio, the ability of Applied Therapeutics Inc 's assets to generate revenue in the third quarter 2025, increased sequentially to 0.02 in the third quarter (Sep 30 2025), APLT's balance sheet remain strong.

Within sector Applied Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APLT Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change -67.74 % -70.78 % -62.37 % 58.02 % 135.79 %
Y / Y Revenue Change 719.67 % - - - -
Asset Turnover Ratio (TTM) 0.02 - - - -0
APLT's Total Ranking # # # # #
Seq. Asset Change -7.95 % -34.38 % -34.32 % -18.69 % -16.6 %
Seq. Revenue Change - - - - -15.28 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




APLT Company Profile • Back to APLT Efficiency Comparisons • Compare APLT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Agape Atp Corporation  0.08 $ 1.485  Millions$ 19.384  Millions
Renovorx Inc   0.08 $ 0.928  Millions$ 12.245  Millions
Longeveron Inc   0.07 $ 1.437  Millions$ 19.678  Millions
Autolus Therapeutics Plc  0.07 $ 51.128  Millions$ 727.998  Millions
Omniab Inc   0.07 $ 21.094  Millions$ 309.276  Millions
Merus N v   0.07 $ 56.606  Millions$ 849.497  Millions
Cytokinetics Incorporated  0.07 $ 87.211  Millions$ 1,331.979  Millions
Scorpius Holdings inc   0.07 $ 1.716  Millions$ 26.276  Millions
Bolt Biotherapeutics Inc   0.06 $ 5.195  Millions$ 81.512  Millions
Therapeuticsmd Inc   0.06 $ 2.363  Millions$ 38.884  Millions
Mountain Crest Acquisition Corp V  0.06 $ 0.077  Millions$ 1.267  Millions
Intellia Therapeutics Inc   0.06 $ 57.528  Millions$ 1,000.337  Millions
Blue Water Vaccines Inc  0.06 $ 1.224  Millions$ 21.439  Millions
Camp4 Therapeutics Corporation  0.05 $ 3.802  Millions$ 69.688  Millions
Arcellx Inc   0.05 $ 35.898  Millions$ 658.603  Millions
Dbv Technologies S a   0.05 $ 5.550  Millions$ 104.682  Millions
Tonix Pharmaceuticals Holding Corp   0.05 $ 10.299  Millions$ 198.890  Millions
Grail Inc   0.05 $ 141.827  Millions$ 2,783.623  Millions
Seer Inc   0.05 $ 16.307  Millions$ 336.238  Millions
Onkure Therapeutics Inc   0.05 $ 4.524  Millions$ 93.423  Millions
Astrotech Corp  0.05 $ 1.312  Millions$ 27.181  Millions
Kyntra Bio Inc   0.05 $ 8.298  Millions$ 173.702  Millions
Nuvation Bio Inc   0.05 $ 26.513  Millions$ 570.475  Millions
Septerna Inc   0.05 $ 22.045  Millions$ 478.115  Millions
Viskase Holdings inc   0.05 $ 2.040  Millions$ 45.291  Millions
Scynexis Inc   0.04 $ 2.932  Millions$ 67.581  Millions
Newamsterdam Pharma Company N v   0.04 $ 35.243  Millions$ 821.143  Millions
Kymera Therapeutics Inc   0.04 $ 43.734  Millions$ 1,032.365  Millions
Beam Therapeutics Inc   0.04 $ 55.701  Millions$ 1,318.246  Millions
Biorestorative Therapies Inc   0.04 $ 0.383  Millions$ 9.191  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.